Dosage guide
Magnesium Glycinate dosage
Magnesium Glycinate dosing: typical range, frequency, half-life, onset, routes. Evidence-tiered.
At a glance
- Typical dose
- 300mg
- Half-life
- 5hr
- Frequency
- daily (often evening)
- Routes
- oral
Protocol
- 1
Measure the dose
Typical Magnesium Glycinate dose is 300 mg. Use a weight-based calculator for individual adjustments.
Open tool → - 2
Set the frequency
Administer daily (often evening). Half-life of 5 hours anchors the dosing interval.
Open tool → - 3
- 4
Monitor for side effects
Watch for: mild GI upset at high doses; loose stools (dose-dependent, less than with oxide/citrate forms). Stop or reduce dose if tolerability breaks down.
Why this dose
Magnesium acts as a cofactor for 300+ enzymes and as a voltage-dependent antagonist at NMDA receptors; glycine serves as an inhibitory neurotransmitter and co-agonist at glycine receptors.
The typical 300 mg dose is the figure most commonly used in published protocols for Magnesium Glycinate. Treat the label as a starting point: body weight, training status, sleep, diet, and concurrent medications all shift the effective dose-response curve in real users.
How to administer
Magnesium Glycinate is administered via the oral route. Oral dosing is straightforward: take with water, with or without food unless specifically noted.
Onset of action runs around 1 hour after administration. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.
Half-life note: Plasma Mg tightly regulated; supplement effects seen in tissue stores over days to weeks rather than acute plasma changes
Cycling and tolerance
No cycling required; continuous daily use is standard
Effects to expect at typical dose
- Shortens sleep onset latency in older adults and in deficient populations supplementing 200 to 400 mg elemental Mg
- Improves subjective sleep quality scores (PSQI, ISI) modestly versus placebo over 4 to 8 weeks
- Reduces nocturnal leg cramps and exercise-induced muscle cramping in some controlled trials
- Lowers self-reported anxiety in mild-to-moderate cases, with smaller effect than first-line pharmacotherapy
- Glycinate form delivers fewer GI side effects than oxide or citrate at equivalent elemental doses
- Insufficient as a stand-alone hypertension treatment; small adjunctive blood-pressure reductions only
Best-graded outcomes
- A Bioavailability versus magnesium oxide : Higher fractional absorption than oxide (Crossover absorption studies).
- A Constipation and GI tolerance : Lower diarrhea rates at equivalent doses (Versus oxide and citrate forms).
- B Sleep onset latency : Faster onset at 200 to 400 mg elemental (Older adults, deficient).
Side effects and interactions
Common side effects
- mild GI upset at high doses
- loose stools (dose-dependent, less than with oxide/citrate forms)
Notable interactions
- tetracycline and fluoroquinolone antibiotics (moderate): magnesium chelates antibiotic, reducing absorption; separate by 2+ hours
- bisphosphonates (moderate): reduced absorption of bisphosphonate
- potassium-sparing diuretics (moderate): possible hypermagnesemia in renal impairment
Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full Magnesium Glycinate profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.
Regulatory snapshot
- WADA status
- allowed
- DEA / Rx
- OTC supplement
- Pregnancy
- Generally considered acceptable at RDA doses; consult clinician
- Legal status
- Dietary supplement
Do not use if
- severe renal impairment
- myasthenia gravis
- heart block
Related calculators
Related research